Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multivariate analysis of factors affecting pulmonary function in bronchiectasis

M Ip1, I J Lauder, W Y Wong

  • 1Department of Medicine, University of Hong Kong.

Respiration; International Review of Thoracic Diseases
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Across time and space: phylogenetic analysis of carbapenem-resistant Acinetobacter baumannii in a network of general and convalescent hospitals.

The Journal of hospital infection·2025
Same author

Skin microbial signatures for eczema: a birth cohort study (abridged secondary publication).

Hong Kong medical journal = Xianggang yi xue za zhi·2024
Same author

Gut microbiome and symptoms in females with irritable bowel syndrome: a cross-sectional analysis.

Beneficial microbes·2024
Same author

Limb presentations of invasive Group A Streptococci infection in children.

JPRAS open·2024
Same author

Air dispersal of multi-drug-resistant organisms including meticillin-resistant Staphylococcus aureus, carbapenem-resistant Acinetobacter baumannii and carbapenemase-producing Enterobacterales in general wards: surveillance culture of air grilles.

The Journal of hospital infection·2024
Same author

Faecal microbiota transplantation for patients with irritable bowel syndrome: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2024

Persistent inflammation significantly worsens lung function in bronchiectasis patients. Factors like bronchial hyperresponsiveness and increased sputum volume are linked to poorer pulmonary function, highlighting inflammation

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Clinical Investigation

Background:

  • Impaired pulmonary function is a critical prognostic indicator in bronchiectasis.
  • Understanding factors influencing lung function is essential for managing bronchiectasis.
  • Inflammation is suspected to play a key role in lung function decline.

Purpose of the Study:

  • To identify clinical, inflammatory, and sputum-related factors associated with impaired pulmonary function in bronchiectasis.
  • To analyze the impact of bronchial hyperresponsiveness, atopy, and systemic inflammation on lung function.

Main Methods:

  • Studied 82 Chinese patients with bronchiectasis, assessing clinical features, atopy, bronchial responsiveness, systemic inflammation, and sputum characteristics.
  • Utilized spirometry and carbon monoxide diffusing capacity for pulmonary function assessment.

Related Experiment Videos

  • Employed multivariate analysis to determine significant associations with lung function parameters.
  • Main Results:

    • Majority of patients exhibited airflow obstruction; bronchial hyperresponsiveness, asthma, higher serum globulin, elevated leucocyte count, lower serum albumin, increased sputum volume, diffuse disease, and older age were linked to worse lung function.
    • Excluding asthma patients revealed similar factors plus longer disease duration, sputum eosinophils, and higher sputum elastolytic activity (EA) associated with poorer spirometry.
    • Identified factors predominantly reflect an ongoing inflammatory state.

    Conclusions:

    • Persistent inflammation is a significant driver of lung function deterioration in bronchiectasis.
    • Bronchial hyperresponsiveness, sputum characteristics, and systemic inflammatory markers are key factors influencing pulmonary function.
    • Targeting inflammation may be crucial for improving lung function outcomes in bronchiectasis patients.